Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BECTON DICKINSON & CO Director's Dealing 2020

Nov 30, 2020

30003_dirs_2020-11-30_12446ec8-e5a9-41b3-a9bc-6280fab24e1c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
Period of Report: 2020-11-26

Reporting Person: Mas Ribo Alberto (EVP and Pres, Life Sciences)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-11-26 Common Stock A 949 $0.0 Acquired 9330 Direct
2020-11-26 Common Stock F 672 $0.0 Disposed 8658 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-11-26 Stock Appreciation Rights $227.47 A 21694 Acquired 2030-11-26 Common Stock (21694) Direct
2020-11-26 Stock Appreciation Rights $227.47 A 5893 Acquired 2030-11-26 Common Stock (5893) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2554 Indirect
Common Stock 1080 Indirect

Footnotes

F1: Represents shares vesting under performance units granted on November 26, 2017.

F2: Represents shares withheld for payment of withholding taxes in connection with (A) vesting of the performance units referred to in footnote (1) and (B) the vesting of restricted stock units as previously reported on Table I.

F3: Represents shares of common stock held under the Becton, Dickinson and Company Global Share Investment Program (the "GSIP"). The information presented for the GSIP is as of May 31, 2019.

F4: Represents shares of common stock held under the Becton, Dickinson and Company Savings Incentive Plan (the "SIP"). The information presented for the SIP is as of May 31, 2019.

F5: The stock appreciation rights vest in four annual installments beginning November 26, 2021.

F6: The stock appreciation rights vest in three annual installments beginning November 26, 2021.